Pradaxa

News & Analysis as of

Pradaxa and Actos: Is Non-Preservation of Documents an Emerging Trend?

When a US District Court judge fined Boehringer Ingelheim almost $1 million at the end of last year for failure to preserve documents regarding the blood thinner Pradaxa, the decision served as a precursor to a similar...more

Boehringer Ingelheim to Pay $650M to Settle Pradaxa Claims

German drugmaker to settle about 4,000 plaintiff’s Pradaxa claims for $650M. Claimants’ Negotiating Counsel achieved a $650M Settlement in In Re Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385,...more

FDA Rallies Around Pradaxa with New Study, Still No Antidote

A review by the FDA finds no additional risk of myocardial infarcation (MI) or a heart attack when Pradaxa (dabigatran) is compared to Coumadin (warfarin). An MI occurs when blood suddenly stops flowing to parts of the heart...more

Love, But Don’t Leave, Your Litigation Holds

If your company is like many organizations, once a legal hold is set in motion, it becomes yesterday’s news…and is promptly forgotten about in favor of more pressing matters. After all, at its essence, a litigation hold is...more

4 Results
|
View per page
Page: of 1